ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 669517 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 669517; 2) Community: the network communities that were significantly associated with the response to NSC 669517; 3) Molecule: the relationships between components within communities and NSC 669517; 4) MDR: the compounds that were significantly associated with the NSC 669517.

NSC Compound Enrichment Correlation
NSC 718729 Cyclopent-4-ene-1,3-dione, 2-[[4-hydroxy-3,5-bis(1,1-dimethylethyl)phenyl]methyl]- 0.0291420747327558 0.46096582
NSC 726184 1,4-di-N-oxide-2-cyano-6,7-difluoro-3-(4-methyl)phenylquinox aline 0.0291420747327558 0.26999697
NSC 726769 5,6-Dihydro-6-(4-amino-1-butyl)-5,11-dioxo-11H-indeno{1,2-c] isoquinoline Hydrochloride 0.0291420747327558 0.070172685
NSC 744989 7-methoxy-8-[(5-2-methoxy-4-[(E)-3-(2,4-dimethyl-3-quinolyl)-3-oxo-1-propenyl]phenoxybutyl)oxy]-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-5-one 0.0291420747327558 0.2378127
NSC 762008 Copper(II) complex with a thiosemicarbazone as a ligand 0.0291420747327558 0.41211056
NSC 105132 Deoxycamptothecin 0.029142074732756 -0.069461668
NSC 134723 K 31 0.029142074732756 -0.12993117
NSC 135073 WITHACNISTIN 0.029142074732756 0.67982315
NSC 292816 1-Butanone, 1,1'-(9-ethyl-9H-carbazole-3,6-diyl)bis[4-(dimethylamino)-, (E)-2-butenedioate (1:1) 0.029142074732756 0.07241235
NSC 295499 Camptothecin Derivative 0.029142074732756 -0.1134509
Total:46  Current:26    [First] [Prev] [Next] [Last]